| 國立成功大學 |
2023 |
Discovery and characterization of cross-reactive intrahepatic antibodies in severe alcoholic hepatitis
|
Ahmadi, Ahmadi A.R.;Song, G.;Gao, T.;Ma, J.;Han, X.;Hu, M.-W.;Cameron, A.M.;Wesson, R.N.;Philosophe, B.;Ottmann, S.;King, E.;Gurakar, A.;Qi, L.;Peiffer, B.;Burdick, J.;Anders, R.;Zhou, Zhou Z.;Lu, H.;Feng, D.;Chen, Chen C.-S.;Qian, J.;Gao, B.;Zhu, H.;Sun, Z. |
| 臺大學術典藏 |
2021-07-06T02:37:31Z |
Association between prior use of anti-diabetic medication and breast cancer stage at diagnosis
|
Fahim S.M.; Hsu C.-H.; FANG-JU LIN; Qian J.; Chou C. |
| 臺大學術典藏 |
2021-07-03T03:34:18Z |
Phase 2 trial of linifanib (ABT-869) in patients with unresectable or metastatic hepatocellular carcinoma
|
Toh H.C.; PEI-JER CHEN; Carr B.I.; Knox J.J.; Gill S.; Ansell P.; McKeegan E.M.; Dowell B.; Pedersen M.; Qin Q.; Qian J.; Scappaticci F.A.; Ricker J.L.; Carlson D.M.; Yong W.P. |
| 臺大學術典藏 |
2021-07-03T03:33:57Z |
Linifanib versus sorafenib in patients with advanced hepatocellular carcinoma: Results of a randomized phase III trial
|
Cainap C.; Qin S.; Huang W.-T.; Chung I.J.; Pan H.; Cheng Y.; Kudo M.; Kang Y.-K.; PEI-JER CHEN; Toh H.-C.; Gorbunova V.; Eskens F.A.L.M.; Qian J.; McKee M.D.; Ricker J.L.; Carlson D.M.; El-Nowiem S. |
| 臺大學術典藏 |
2021-06-15T03:11:59Z |
Asian Organization for Crohn's and Colitis and Asian Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 1: Risk assessment
|
Park D.I.I.; Hisamatsu T.; Chen M.; Ng S.C.; Ooi C.J.; SHU-CHEN WEI; Banerjee R.; Hilmi I.N.; Jeen Y.T.; Han D.S.; Kim H.J.; Ran Z.; Wu K.; Qian J.; Hu P.-J.; Matsuoka K.; Andoh A.; Suzuki Y.; Sugano K.; Watanabe M.; Hibi T.; Puri A.S.; Yang S.-K. |
| 臺大學術典藏 |
2021-06-15T03:11:58Z |
Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 2: Management
|
Park D.I.; Hisamatsu T.; Chen M.; Ng S.C.; Ooi C.J.; SHU-CHEN WEI; Banerjee R.; Hilmi I.N.; Jeen Y.T.; Han D.S.; Kim H.J.; Ran Z.; Wu K.; Qian J.; Hu P.-J.; Matsuoka K.; Andoh A.; Suzuki Y.; Sugano K.; Watanabe M.; Hibi T.; Puri A.S.; Yang S.-K. |
| 臺大學術典藏 |
2021-06-15T03:11:58Z |
Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 2: Management
|
Park D.I.; Hisamatsu T.; Chen M.; Ng S.C.; Ooi C.J.; SHU-CHEN WEI; Banerjee R.; Hilmi I.N.; Jeen Y.T.; Han D.S.; Kim H.J.; Ran Z.; Wu K.; Qian J.; Hu P.-J.; Matsuoka K.; Andoh A.; Suzuki Y.; Sugano K.; Watanabe M.; Hibi T.; Puri A.S.; Yang S.-K. |
| 臺大學術典藏 |
2021-06-15T03:11:57Z |
Asian organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 1: Risk assessment
|
Park D.I.; Hisamatsu T.; Chen M.; Ng S.C.; Ooi C.J.; SHU-CHEN WEI; Banerjee R.; Hilmi I.N.; Jeen Y.T.; Han D.S.; Kim H.J.; Ran Z.; Wu K.; Qian J.; Hu P.-J.; Matsuoka K.; Andoh A.; Suzuki Y.; Sugano K.; Watanabe M.; Hibi T.; Puri A.S.; Yang S.-K. |
| 臺大學術典藏 |
2021-06-15T03:11:45Z |
Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology practice recommendations for medical management and monitoring of inflammatory bowel disease in Asia
|
Ran Z.; Wu K.; Matsuoka K.; Jeen Y.T.; SHU-CHEN WEI; Ahuja V.; Chen M.; Hu P.-J.; Andoh A.; Kim H.J.; Yang S.-K.; Watanabe M.; Ng S.C.; Hibi T.; Hilmi I.N.; Suzuki Y.; Han D.S.; Leung W.K.; Sollano J.; Ooi C.J.; Qian J. |
| 臺大學術典藏 |
2020-12-28T06:25:39Z |
Chronic Total Occlusion Wiring: A State-of-the-Art Guide From The Asia Pacific Chronic Total Occlusion Club
|
Wu E.B.; Tsuchikane E.; Lo S.; Lim S.T.; Ge L.; Chen J.-Y.; Qian J.; Lee S.-W.; HSIEN-LI KAO; Harding S.A. |
